Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Taysha Gene Therapies (TSHA)
NASDAQ:TSHA
RESEARCH TOOLSreports
Taysha Gene Therapies (TSHA) Ownership - Who Owns Taysha Gene Therapies?
825 Followers
Taysha Gene Therapies (TSHA) Ownership Overview
20.48% Insiders
12.01% Mutual Funds
10.63% Other Institutional Investors
56.88% Public Companies and Individual Investors
The ownership structure of Taysha Gene Therapies (TSHA) stock is a mix of institutional, retail and individual investors. Approximately 22.64% of the company’s stock is owned by Institutional Investors, 20.48% is owned by Insiders and 56.88% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jul 01, 2024 | Paul B Manning >10% Owner | xxxxxxxxxxxxx | $2999999 |
| Nov 20, 2023 | Paul B Manning >10% Owner | xxxxxxxxxxxxx | $163000 |
| Aug 16, 2023 | Paul B Manning >10% Owner | xxxxxxxxxxxxx | $14820000 |
| Aug 16, 2023 | Philip Donenberg Director | xxxxxxxxxxxxx | $100000 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Mar 31, 2024 | xxxxxxxxxxxxx | $352737 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $31204083 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 10,992,802 | Institution | 5.46% | 26,052,941 | |
| 10,872,503 | Institution | 5.40% | 25,767,832 | |
| 7,473,477 | Institution | 3.71% | 17,712,140 | |
| 7,197,675 | Institution | 3.57% | 17,058,490 | |
| 6,021,535 | Institution | 2.99% | 14,271,038 | |
| 5,690,075 | Institution | 2.83% | 13,485,478 | |
| 5,679,180 | Institution | 2.82% | 13,459,657 | |
| 4,004,756 | Institution | 1.99% | 9,491,272 | |
| 818,309 | Institution | 0.41% | 1,939,392 | |
| 326,488 | Institution | 0.16% | 773,777 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 10,992,802 | Institution | 5.46% | 26,052,941 | |
| 6,021,535 | Institution | 2.99% | 14,271,038 | |
| 5,690,075 | Institution | 2.83% | 13,485,478 | |
| 818,309 | Institution | 0.41% | 1,939,392 | |
| 243,880 | Institution | 0.12% | 577,996 | |
| 150,700 | Institution | 0.07% | 357,159 | |
| 102,518 | Institution | 0.05% | 242,968 | |
| 88,081 | Institution | 0.04% | 208,752 | |
| 26,474 | Institution | 0.01% | 62,743 | |
| 21,044 | Institution | 0.01% | 49,874 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,026,826 | Institution | 2.00% | 13,812,013 | |
| 3,972,816 | Institution | 1.97% | 9,773,127 | |
| 2,469,279 | Institution | 1.23% | 6,074,426 | |
| 2,469,279 | Institution | 1.23% | 6,074,426 | |
| 2,469,279 | Institution | 1.23% | 6,074,426 | |
| 1,439,752 | Institution | 0.71% | 4,938,349 | |
| 1,416,746 | Institution | 0.70% | 3,357,688 | |
| 1,023,255 | Institution | 0.51% | 2,425,114 | |
| 344,717 | Institution | 0.17% | 816,979 | |
| 314,039 | Institution | 0.16% | 744,272 |
FAQ
Who Owns Taysha Gene Therapies (TSHA)?
According to the latest TipRanks data, approximately 10.63% of the company's stock is held by institutional investors, 20.48% is held by insiders, and 56.88% is held by retail investors.
What percentage of Taysha Gene Therapies (TSHA) stock is held by institutional investors?
According to the latest TipRanks data, approximately 10.63% of Taysha Gene Therapies (TSHA) stock is held by institutional investors.
What percentage of Taysha Gene Therapies (TSHA) stock is held by retail investors?
According to the latest TipRanks data, approximately 56.88% of Taysha Gene Therapies (TSHA) stock is held by retail investors.
Who owns the most shares of Taysha Gene Therapies (TSHA)?
Fidelity Select Portfolios owns the most shares of Taysha Gene Therapies (TSHA).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.